NCAA Division I Council Vote to Remove Cannabinoids from Banned Drug Class Regarding Championships
The NCAA Division I Council recently voted to remove cannabinoids from their banned drug class for postseason football and NCAA championships.
NCAA logo | Image Credit: © jetcityimage - adobe.stock.com.
On June 25, 2024, the National Collegiate Athletics Association (NCAA) Division I Council met and voted to remove cannabinoids from the banded drug class involving NCAA championships and postseason football. This ruling was set to go into effect immediately (1).
Previous NCAA policy stated that (2), “cannabinoids are one of five substances tested for ahead of championships and postseason football games. The NCAA also tests for beta-2 agonists, beta blockers (in rifle), stimulants and narcotics ahead of those events.” If an athlete tests positive for cannabis, it could lead to them receiving a suspension. During the season, schools maintain their own drug testing standards, while the NCAA managed drug testing during the postseason. If a positive test result shows up on a test conducted by the NCAA, a harsher penalty is usually handed down than what the school would have enacted (1).
“The NCAA drug testing program is intended to focus on integrity of competition, and cannabis products do not provide a competitive advantage,” Josh Whitman, Council chair and Illinois athletic director, commented (1). “The council’s focus is on policies centered on student-athlete health and well-being rather than punishment for cannabis use.”
The New York Times reported that back in 2019 (1), three football players in Oklahoma received a six-game suspension because the student athletes had tested positive for cannabis prior to the Peach Bowl College Football Playoff (CFP) semifinal game. As a postseason game, the athletes’ suspensions were continued into the following 2020 season.
In a September 2023 NCAA press release (3), the National Collegiate Athletic Association (NCAA) Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) formally announced their recommendation that cannabis should be removed from the organization’s banned substances list for college athletes. The committee also stated that all three of the organization’s governing bodies should “introduce and adopt legislation that would remove cannabinoids from the list of NCAA banned drug classes.”
This recommendation was offered after an extensive study informed by industry and subject matter experts. In December 2022, the NCAA also hosted a Summit on Cannabinoids in College Athletics (4). The consensus opinion formed at that event was that cannabis was not a performance-enhancing drug and that a harm-reduction approach to cannabis would be best implemented at the school level.
With the NCAA Division I Council’s ruling, it will hopefully ignite future changes in sport regulations. The Pew Research Center reported that as of April 2024, 24 stated in the United States (US) have legalized recreational cannabis (5). Although the popularity of cannabis is growing, it still faces various roadblocks stalling it from being an accepted option for both athletes and recreational and medical consumers.
References
- Vannini, C. NCAA DI removes cannabinoids from banned drug class https://www.nytimes.com/athletic/5591752/2024/06/25/ncaa-cannabinoids-banned-drugs-football/ (accessed Jun 28, 2024).
- Schultz, N.; Samra, S. NCAA makes surprising decision on removing banned drug from list https://www.on3.com/news/ncaa-division-i-council-vote-remove-cannabinoids-banned-drug-class-football-postseason-participation/ (accessed Jul 24, 2024).
- Colli, M. NCAA committee recommends removal of cannabis from banned substances list https://www.cannabissciencetech.com/view/ncaa-committee-recommends-removal-of-cannabis-from-banned-substances-list (accessed Jul 24, 2024).
- Radford, C. Summit addresses impact of cannabinoids on student-athlete health, safety and performance, NCAA.org, https://www.ncaa.org/news/2022/12/20/media-center-summit-addresses-impact-of-cannabinoids-on-student-athlete-health-safety-and-performance.aspx#:~:text=In%20February%202022%2C%20CSMAS%20adjusted,penalty%20str
- Breen, K.; Johnston, T. Maps show states where weed is legal for recreational, medical use in 2024 https://www.cbsnews.com/news/legal-weed-map-states/ (accessed Jul 24, 2024).
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
